Compared to the number of CTCs expressing MCT1, there appears to be a greater proportion that expresses MCT4, which is expected considering the hypoxic nature of SCLC tumours and the CTCs that disseminate from them. The gene discussed is SLC16A4; the disease is neoplasm.